Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159–65.

Article  PubMed  Google Scholar 

Yiangou A, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms. Nat Rev Neurol. 2023;19:769–85.

Article  PubMed  Google Scholar 

O’Reilly MW, Westgate CS, Hornby C, Botfield H, Taylor A, Markey K, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4:e125348.

PubMed  PubMed Central  Google Scholar 

Adderley NJ, Subramanian A, Nirantharakumar K, Yiangou A, Gokhale KM, Mollan SP, et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76:1088–98.

Article  PubMed  PubMed Central  Google Scholar 

Westgate CSJ, Markey K, Mitchell JL, Yiangou A, Singhal R, Stewart P, et al. Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension. Eur J Endocrinol. 2022;187:323–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hardy RS, Botfield H, Markey K, Mitchell J, Alimajstorovic Z, Westgate CSJ, et al. 11βHSD1 Inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension. J Clin Endocrinol Metab. 2020;106:174–87.

Article  PubMed Central  Google Scholar 

Hornby C, Botfield H, O’Reilly MW, Westgate CSJ, Mitchell J, Mollan SP, et al. Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning. Neuroophthalmology. 2018;42:99–104.

Article  PubMed  Google Scholar 

Westgate CS, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G, et al. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 2021;6:e145346.

Article  PubMed  PubMed Central  Google Scholar 

Hornby C, Mollan SP, Botfield H, O’Reilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38:522–30.

Article  PubMed  PubMed Central  Google Scholar 

McCluskey G, Doherty-Allan R, McCarron P, Loftus AM, McCarron LV, Mulholland D, et al. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 2018;25:1218–27.

Article  CAS  PubMed  Google Scholar 

Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye. 2019;33:478–85.

Article  PubMed  Google Scholar 

Shaia JK, Sharma N, Kumar M, Chu J, Maatouk C, Talcott K, et al. Changes in prevalence of idiopathic intracranial hypertension in the United States between 2015 and 2022, stratified by sex, race, and ethnicity. Neurology. 2024;102:e208036.

Article  PubMed  Google Scholar 

Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ. What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals. BMJ Open. 2019;9:e026573.

Article  PubMed  PubMed Central  Google Scholar 

Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89:1088–1100.

Article  PubMed  Google Scholar 

Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19:93.

Article  PubMed  PubMed Central  Google Scholar 

Abbott S, Denton A, Wong SH, Mollan SP, Bul KC. Weight management communications in idiopathic intracranial hypertension: challenges and recommendations from the patients’ perspective. BMJ Neurol Open. 2023;5:e000527.

Article  PubMed  PubMed Central  Google Scholar 

Lyons HS, Mollan SLP, Liu GT, Bowman R, Thaller M, Sinclair AJ, et al. Different characteristics of pre-pubertal and post-pubertal idiopathic intracranial hypertension: a narrative review. Neuroophthalmology. 2022;47:63–74.

Article  PubMed  PubMed Central  Google Scholar 

Mollan SP, Chong YJ, Grech O, Sinclair AJ & Wakerley BR. Current perspectives on idiopathic intracranial hypertension without papilloedema. Life 2021 11, https://doi.org/10.3390/life11060472.

Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, Wall M, and the NORDIC IIHTT Study Group. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache. 2017;57:1195–205.

Article  PubMed  PubMed Central  Google Scholar 

Mollan SP, Grech O, Sinclair AJ. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review. Headache. 2021;61:808–16.

Article  PubMed  Google Scholar 

Mollan SP, Spitzer D, Nicholl DJ. Raised intracranial pressure in those presenting with headache. BMJ. 2018;363:k3252.

Article  PubMed  Google Scholar 

Mollan SP, Virdee JS, Bilton EJ, Thaller M, Krishan A, Sinclair AJ. Headache for ophthalmologists: current advances in headache understanding and management. Eye. 2021;35:1574–86.

Article  PubMed  PubMed Central  Google Scholar 

Mollan SP, Wakerley BR, Alimajstorovic Z, Mitchell J, Ottridge R, Yiangou A, et al. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension. J Headache Pain. 2021;22:118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71:693–701.

Article  PubMed  PubMed Central  Google Scholar 

Fisayo A, Bruce BB, Newman NJ, Biousse V. Overdiagnosis of idiopathic intracranial hypertension. Neurology. 2016 ;86(Jan):341–50.

Article  PubMed  PubMed Central  Google Scholar 

Shin HJ, Costello F. Imaging the optic nerve with optical coherence tomography. Eye. 2024 in press.

Littlewood R, Mollan SP, Pepper IM, Hickman SJ. The utility of fundus fluorescein angiography in neuro-ophthalmology. Neuroophthalmology. 2019;43:217–34.

Article  PubMed  PubMed Central  Google Scholar 

Pineles SL, Arnold AC. Fluorescein angiographic identification of optic disc drusen with and without optic disc edema. J Neuro-Ophthalmol. 2012;32:17–22.

Article  Google Scholar 

Mollan SP, Hornby C, Mitchell J, Sinclair AJ. Evaluation and management of adult idiopathic intracranial hypertension. Pr Neurol. 2018;18:485–8.

Article  Google Scholar 

Mollan SP, Ball AK, Sinclair AJ, Madill SA, Clarke CE, Jacks AS, et al. Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol. 2009;62:105–8.

Article  CAS  PubMed  Google Scholar 

Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Anemia and papilledema. Am J Ophthalmol. 2003;135:437–46.

Article  PubMed  Google Scholar 

Plant GT, Wong SH, Sundholm A, Mollan SP. Idiopathic intracranial hypertension and anemia: a matched case-control study. J Neuroophthalmol. 2021;41:e272–e273.

Article  PubMed  Google Scholar 

Tan MG, Worley B, Kim WB, Ten Hove M, Beecker J. Drug-Induced intracranial hypertension: a systematic review and critical assessment of drug-induced causes. Am J Clin Dermatol. 2020;21:163–72.

Article  PubMed  Google Scholar 

Hyder YF, Homer V, Thaller M, Byrne M, Tsermoulas G, Piccus R, et al. Defining the phenotype and prognosis of people with idiopathic intracranial hypertension after cerebrospinal fluid diversion surgery. Am J Ophthalmol. 2023;250:70–81.

Article  PubMed  Google Scholar 

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311:1641–51.

Article  Google Scholar 

Abbott S, Chan F, Tahrani AA, Wong SH, Campbell FEJ, Parmar C, et al. Weight management interventions for adults with idiopathic intracranial hypertension: a systematic review and practice recommendations. Neurology. 2023;101:e2138–e2150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mollan SP, Mitchell JL, Ottridge RS, Aguiar M, Yiangou A, Alimajstorovic Z, et al. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol 2021;78:678–86.

Article  PubMed  PubMed Central  Google Scholar 

Elliot L, Frew E, Mollan SP, Mitchell JL, Yiangou A, Alimajstorovic Z, et al. Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer healthcare system. Surg Obes Relat Dis. 2021;17:1310–6.

Article  PubMed  PubMed Central  Google Scholar 

Mollan SP, Mitchell JL, Yiangou A, Ottridge RS, Alimajstorovic Z, Cartwright DM, et al. Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension. Neurology. 2022;99:e1090–e1099.

Article  PubMed  PubMe